In vivo antitumor effect of cromolyn in PEGylated liposomes for pancreatic cancer
A PEGylated liposomal formulation of cromolyn, composed of dipalmitoylphosphatidylcholine (DPPC), dimyristoylphosphatidylcholine (DMPC), distearoylphosphatidylcholine (DSPC) and 1,2-distearoyl-sn-glycero-3-phospho-ethanolamine-N-[methoxy(polyethyleneglycol)-2000] (DSPE-mPEG2000), has been developed...
Saved in:
Published in | Journal of controlled release Vol. 157; no. 2; pp. 190 - 195 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Kidlington
Elsevier B.V
30.01.2012
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A PEGylated liposomal formulation of cromolyn, composed of dipalmitoylphosphatidylcholine (DPPC), dimyristoylphosphatidylcholine (DMPC), distearoylphosphatidylcholine (DSPC) and 1,2-distearoyl-sn-glycero-3-phospho-ethanolamine-N-[methoxy(polyethyleneglycol)-2000] (DSPE-mPEG2000), has been developed with the purpose of improving the antitumor activity of cromolyn for human pancreatic adenocarcinoma. In stability study, the amount of proteins adsorbed onto the PEGylated liposomes encapsulating cromolyn was 4.5-fold lower than the non-PEGylated liposome. In vitro study showed that the cromolyn in PEGylated liposome exhibited better anti-proliferative effect in BxPC-3 cells than in Panc-1 cells, which indicates higher level of endogenous S100P protein in BxPC-3 cells than in Panc-1 cells as a target protein for this drug. Moreover, the combination of cromolyn with gemcitabine in PEGylated liposomes demonstrated the strongest cytotoxicity to BxPC-3 pancreatic cancer cells in vitro and the highest anti-tumor activity against the BxPC-3 tumor bearing nude mice in vivo. Thus, this PEGylated liposomal formulation of cromolyn is expected to provide a novel approach to the treatment of pancreatic cancer in the future.
Improved therapeutic efficacy of PEGylated liposomal cromolyn (PEG-lipo-cro) in BxPC-3 pancreatic cancer xenograft mice. [Display omitted] |
---|---|
Bibliography: | http://dx.doi.org/10.1016/j.jconrel.2011.09.066 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
ISSN: | 0168-3659 1873-4995 |
DOI: | 10.1016/j.jconrel.2011.09.066 |